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Table 1 Lipid and glucose parameters for before and 1 – 8 h after loading with test meal
A. All participants
Elapsed time (h)
0 1 2 4 6 8
TC (mg/dL) 182.4 ± 32.8 180.2 ± 32.8 178.2 ± 31.3 180.4 ± 30.1 184.0 ± 31.6 188.2 ± 32.5
LDL-C (mg/dL) 98.5 ± 26.1 96.3 ± 25.5 95.6 ± 25.5 96.7 ± 24.7 99.8 ± 25.6 102.1 ± 26.2
HDL-C (mg/dL) 70.1 ± 15.4 68.3 ± 15.4 66.2 ± 14.1 68.3 ± 15.0 70.2 ± 15.7 72.0 ± 16.0
Sd-LDL-C (mg/dL) 22.4 ± 12.1 19.8 ± 8.8 18.8 ± 8.5 18.6 ± 7.1 18.6 ± 7.1 19.0 ± 7.0
OxLDL (U/mL) 7.38 ± 4.96 7.04 ± 4.98 7.25 ± 5.74 7.41 ± 5.53 7.71 ± 5.41 8.38 ± 5.46
TG (mg/dL) 69.8 ± 31.2 92.1 ± 41.0* 103.9 ± 51.4† 72.9 ± 40.4 70.7 ± 34.3 53.9 ± 23.8
Non-HDL-C (mg/dL) 112.3 ± 30.1 112.0 ± 29.9 112.0 ± 29.3 112.0 ± 28.4 113.8 ± 28.7 116.3 ± 29.4
RemL-C (mg/dL) 3.51 ± 1.84 4.35 ± 2.11 4.29 ± 2.46 3.90 ± 2.38 3.22 ± 1.61 2.98 ± 1.40
RLP-C (mg/dL) 3.20 ± 1.30 4.22 ± 1.91* 5.01 ± 2.42‡ 3.88 ± 1.94 3.03 ± 1.02 2.82 ± 0.88
RLP-TG (mg/dL) 16.3 ± 4.0 25.5 ± 14.4† 32.6 ± 21.8‡ 21.1 ± 12.3 15.8 ± 3.4 15.3 ± 2.0
ApoA-I (mg/dL) 161.2 ± 26.6 159.8 ± 27.3 158.7 ± 25.2 160.3 ± 25.2 163.3 ± 26.4 165.7 ± 27.0
ApoA-II (mg/dL) 37.6 ± 6.0 37.3 ± 6.2 36.8 ± 6.0 37.4 ± 5.9 37.7 ± 5.9 38.4 ± 6.1
ApoB (mg/dL) 66.6 ± 15.3 65.7 ± 15.1 65.0 ± 14.5 66.2 ± 14.5 67.9 ± 14.8 69.3 ± 15.2
ApoC-II (mg/dL) 3.2 ± 1.2 3.3 ± 1.2 3.3 ± 1.2 3.3 ± 1.2 3.3 ± 1.1 3.3 ± 1.1
ApoC-III (mg/dL) 9.5 ± 2.4 9.8 ± 2.5 9.4 ± 2.3 9.2 ± 2.2 9.0 ± 2.1 9.0 ± 2.2
ApoE (mg/dL) 4.3 ± 1.1 4.3 ± 1.1 4.3 ± 1.0 4.2 ± 1.1 4.1 ± 1.0 4.2 ± 1.1
Non-HDL-C/HDL-C 1.70 ± 0.73 1.75 ± 0.75 1.80 ± 0.75 1.75 ± 0.76 1.73 ± 0.74 1.72 ± 0.73
LDL-C/HDL-C 1.50 ± 0.60 1.50 ± 0.61 1.52 ± 0.61 1.50 ± 0.61 1.51 ± 0.60 1.50 ± 0.60
ApoB/apoA-I 0.43 ± 0.13 0.42 ± 0.13 0.42 ± 0.13 0.43 ± 0.13 0.43 ± 0.13 0.43 ± 0.13
Non-HDL-C/apo B 1.67 ± 0.10 1.69 ± 0.10 1.71 ± 0.11 1.68 ± 0.10 1.67 ± 0.10 1.67 ± 0.10
TG/apoB 1.06 ± 0.44 1.41 ± 0.56§ 1.61 ± 0.71‡ 1.25 ± 0.61 0.93 ± 0.40 0.79 ± 0.32
Plasma glucose (mg/dL) 89.9 ± 5.7 96.9 ± 20.0§ 87.5 ± 10.8 87.6 ± 4.9 88.1 ± 5.7 87.2 ± 5.7
Insulin (μU/mL) 5.6 ± 2.4 42.4 ± 24.6‡ 18.5 ± 14.1‡ 5.0 ± 2.2 4.2 ± 2.1 3.8 ± 1.7
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Table 1 Lipid and glucose parameters for before and 1 – 8 h after loading with test meal (Continued)
B. Men
TC (mg/dL) 183.1 ± 33.8 181.4 ± 34.5 180.0 ± 33.3 182.4 ± 32.5 185.0 ± 33.2 189.5 ± 34.9
LDL-C (mg/dL) 101.1 ± 28.2 99.0 ± 27.5 99.3 ± 27.7 99.8 ± 26.9 102.7 ± 27.8 105.3 ± 28.8
HDL-C (mg/dL) 66.3 ± 16.7 64.7 ± 17.4 62.5 ± 15.5 65.1 ± 17.2 66.5 ± 17.4 68.3 ± 17.9
Sd-LDL-C (mg/dL) 23.9 ± 11.0 22.2 ± 10.2 21.4 ± 9.5 20.4 ± 9.0 19.8 ± 8.0 20.6 ± 7.8
OxLDL (U/mL) 7.98 ± 5.48 7.91 ± 5.54 8.12 ± 6.19 8.32 ± 6.11 8.70 ± 6.22 9.44 ± 6.12
TG (mg/dL) 78.9 ± 36.0 106.3 ± 45.1 119.5 ± 58.9† 94.8 ± 51.2 68.6 ± 33.7 60.2 ± 28.6
Non-HDL-C (mg/dL) 116.8 ± 32.5 116.8 ± 32.2 117.5 ± 31.8 117.3 ± 31.1 118.5 ± 31.2 121.2 ± 32.5
RemL-C (mg/dL) 4.08 ± 2.13 4.99 ± 2.42 5.16 ± 2.81 4.69 ± 2.80 3.67 ± 1.91 3.36 ± 1.66
RLP-C (mg/dL) 3.62 ± 1.51 5.00 ± 2.03* 5.82 ± 2.76‡ 4.53 ± 2.23 3.31 ± 1.13 3.04 ± 1.01
RLP-TG (mg/dL) 17.3 ± 5.1 30.0 ± 16.7§ 37.8 ± 26.2‡ 24.7 ± 15.2 16.4 ± 4.5 15.6 ± 2.6
ApoA-I (mg/dL) 155.7 ± 29.2 154.4 ± 29.9 154.3 ± 28.7 155.2 ± 29.0 157.9 ± 29.4 160.6 ± 30.4
ApoA-II (mg/dL) 33.8 ± 6.7 38.7 ± 6.8 38.4 ± 6.6 38.8 ± 6.5 39.1 ± 6.7 39.8 ± 6.8
ApoB (mg/dL) 68.8 ± 16.3 68.3 ± 16.3 67.5 ± 15.6 68.8 ± 15.8 70.5 ± 16.0 71.8 ± 16.7
ApoC-II (mg/dL) 3.5 ± 1.1 3.6 ± 1.1 3.6 ± 1.2 3.6 ± 1.2 3.6 ± 1.1 3.5 ± 1.1
ApoC-III (mg/dL) 9.7 ± 2.6 10.2 ± 2.8 9.8 ± 2.7 9.5 ± 2.5 9.2 ± 2.3 9.2 ± 2.4
ApoE (mg/dL) 4.1 ± 1.1 4.1 ± 1.1 4.2 ± 1.0 4.0 ± 1.1 3.9 ± 1.0 4.0 ± 1.0
Non-HDL-C/HDL-C 1.90 ± 0.85 1.96 ± 0.88 2.02 ± 0.87 1.96 ± 0.89 1.94 ± 0.86 1.92 ± 0.86
LDL-C/HDL-C 1.64 ± 0.71 1.66 ± 0.72 1.70 ± 0.70 1.66 ± 0.72 1.67 ± 0.71 1.66 ± 0.71
ApoB/apoA-I 0.46 ± 0.15 0.46 ± 0.15 0.46 ± 0.15 0.46 ± 0.16 0.46 ± 0.15 0.46 ± 0.15
Non-HDL-C/apo B 1.69 ± 0.10 1.70 ± 0.11 1.73 ± 0.12 1.70 ± 0.11 1.67 ± 0.10 1.68 ± 0.11
TG/apoB 1.17 ± 0.52 1.58 ± 0.63 1.79 ± 0.84† 1.41 ± 0.73 1.00 ± 0.49 0.86 ± 0.39
Plasma glucose (mg/dL) 91.1 ± 5.9 97.7 ± 19.9 85.7 ± 9.7 89.2 ± 4.6 88.7 ± 5.9 87.7 ± 5.9
Insulin (μU/mL) 5.0 ± 2.1 33.6 ± 13.7‡ 11.6 ± 7.4† 4.5 ± 2.0 3.8 ± 2.3 3.7 ± 1.8
C. Women
TC (mg/dL) 181.4 ± 32.3 178.6 ± 31.3 175.7 ± 29.1 177.6 ± 27.1 182.7 ± 30.0 186.5 ± 29.6
LDL-C (mg/dL) 95.1 ± 23.3 92.6 ± 22.6 90.6 ± 21.8 92.5 ± 21.4 95.7 ± 22.2 97.7 ± 22.1
HDL-C (mg/dL) 75.3 ± 12.0 73.2 ± 10.9 71.3 ± 10.3 72.8 ± 10.4 75.4 ± 11.6 77.0 ± 11.6
Sd-LDL-C (mg/dL) 20.3 ± 13.6 16.5 ± 4.9 15.3 ± 5.3 16.1 ± 4.6 16.8 ± 5.5 16.7 ± 5.2
OxLDL (U/mL) 6.55 ± 4.15 5.86 ± 3.91 6.06 ± 4.99 6.17 ± 4.48 6.37 ± 3.83 6.92 ± 4.10
TG (mg/dL) 57.3 ± 16.8 72.7 ± 24.6 82.6 ± 28.3‖ 63.7 ± 17.0 52.8 ± 12.4 45.2 ± 10.3
Non-HDL-C (mg/dL) 106.1 ± 25.9 105.4 ± 25.8 104.4 ± 24.2 104.8 ± 23.2 107.3 ± 24.3 109.5 ± 23.9
RemL-C (mg/dL) 2.73 ± 0.95 3.47 ± 1.16 3.11 ± 1.13 2.83 ± 0.95 2.60 ± 0.77 2.45 ± 0.69
RLP-C (mg/dL) 2.62 ± 0.60 3.16 ± 1.06 3.90 ± 1.22‡ 2.98 ± 0.88 2.66 ± 0.72 2.52 ± 0.54
RLP-TG (mg/dL) 15 19.4 ± 7.0 25.5 ± 11.0‡ 16.2 ± 2.1 15.0 ± 0.2 15
ApoA-I (mg/dL) 168.7 ± 21.0 167.3 ± 21.8 164.8 ± 18.5 167.3 ± 17.3 170.7 ± 20.1 172.7 ± 20.3
ApoA-II (mg/dL) 36.0 ± 4.6 35.4 ± 4.7 34.6 ± 4.4 35.3 ± 4.3 35.8 ± 4.1 36.5 ± 4.5
ApoB (mg/dL) 63.7 ± 13.6 62.2 ± 12.9 61.5 ± 12.5 62.6 ± 12.2 64.4 ± 12.6 65.8 ± 12.4
ApoC-II (mg/dL) 2.8 ± 1.1 2.9 ± 1.1 2.9 ± 1.1 2.9 ± 1.0 2.9 ± 1.0 2.9 ± 1.1
ApoC-III (mg/dL) 9.1 ± 2.0 9.3 ± 2.0 8.9 ± 1.7 8.8 ± 1.6 8.6 ± 1.8 8.7 ± 1.8
ApoE (mg/dL) 4.7 ± 1.0 4.6 ± 1.1 4.5 ± 1.1 4.5 ± 1.1 4.5 ± 1.1 4.6 ± 1.1
Non-HDL-C/HDL-C 1.43 ± 0.38 1.46 ± 0.40 1.48 ± 0.39 1.47 ± 0.40 1.45 ± 0.39 1.45 ± 0.37
LDL-C/HDL-C 1.28 ± 0.33 1.28 ± 0.33 1.29 ± 0.33 1.29 ± 0.34 1.29 ± 0.33 1.29 ± 0.32
ApoB/apoA-I 0.38 ± 0.08 0.37 ± 0.08 0.38 ± 0.08 0.38 ± 0.08 0.38 ± 0.08 0.38 ± 0.08
Non-HDL-C/apo B 1.66 ± 0.11 1.68 ± 0.09 1.69 ± 0.11 1.67 ± 0.08 1.66 ± 0.10 1.66 ± 0.10
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Table 1 Lipid and glucose parameters for before and 1 – 8 h after loading with test meal (Continued)
TG/apoB 0.92 ± 0.26 1.17 ± 0.32‡ 1.36 ± 0.40† 1.04 ± 0.29 0.84 ± 0.22 0.70 ± 0.17
Plasma glucose (mg/dL) 88.3 ± 5.2 95.8 ± 20.6 89.9 ± 12.1 85.5 ± 5.0 87.1 ± 5.1 86.5 ± 5.7
Insulin (μU/mL) 6.5 ± 2.6 54.1 ± 31.1‡ 27.9 ± 15.7‡ 5.6 ± 2.4 4.8 ± 1.8 3.9 ± 1.5
Apo apolipoprotein; HDL-C high-density lipoprotein cholesterol; LDL-C low-density lipoprotein cholesterol; OxLDL oxidized LDL; RemL-C remnant lipoprotein
cholesterol measured using “MetaboLead RemL-C”; RLP-C remnant-like particle-cholesterol measured with “JIMRO II”; RLP-TG remnant-like particle-triglycerides;
Sd-LDL-C small, dense-LDL cholesterol; TC total cholesterol; TG triglycerides. TG, RemL-C, RLP-C, RLP-TG, and TG/apoB were transformed into logarithmic values.
Values are expressed as means ± SD. *p < 0.05, †p < 0.005, ‡p < 0.0001, §p < 0.01, ‖p < 0.001, vs. time 0 (repeated ANOVA with Dunnett’s test).
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